Stay True to Our Original Aspiration, Forge Ahead into the Future|Alphamab Oncology 2025 R&D Day Successfully Held

Stay True to Our Original Aspiration, Forge Ahead into the Future|Alphamab Oncology 2025 R&D Day Successfully Held

SUZHOU, China, Dec. 10, 2025 /PRNewswire/ -- On December 8, 2025, Alphamab Oncology (Stock Code: 9966.HK) successfully held its "Stay True to Our Original Aspiration, Forge Ahead into the Future" 2025 R&D Day in Shanghai. The event focused on...

menu
menu